Ademola Popoola,BUHARI TAJUDEEN,Fidelis Ushie,Hamid Olanipekun. Department of Surgery University of Ilorin Teaching Hospital,Ilorin. Multiple Primary Cancers.

Slides:



Advertisements
Similar presentations
Introduction The incidence of prostate cancer in Asians is lower compared to the Westerners in men with PSA
Advertisements

Diagnosis.
Danny Indelicato, MD CTOS 2012 Ewing Sarcoma of the Axial Skeleton: Early Outcomes from the University of Florida Proton Therapy Program.
Oncology The study of cancer. What is cancer? Any malignant growth or tumor caused by abnormal and uncontrolled cell division May be a tumor but it doesn’t.
Yao 1 Neuroendocrine Tumors James C. Yao, MD Associate Professor Deputy Chairman, Gastrointestinal Medical Oncology University of Texas M. D. Anderson.
Lynch Syndrome and Colorectal Cancer Steven G. Proshan, M.D. Annapolis Colon and Rectal Surgeons Anne Arundel Medical Center November 8,
The Challenge of Prostate Cancer Genitourinary Cancer Center at M. D. Anderson PERSONALIZED MEDICINE.
Prostate Cancer Crisis: Imaging is the Solution Faina Shtern, MD President, AdMeTech Foundation.
A few thoughts on cancer and cancer family syndromes Pamela McGrann, MD. Department of Medical Genetics.
Renal Tumours n Mr C Dawson MS FRCS n Consultant Urologist n Fitzwilliam Hospital n Peterborough.
Cancer Genetics Diane Stirling McMillan Nurse Specialist in Genetics
Pancreas Cancer Nimisha K. Parekh, MD, MPH
April 6, o What is cancer? o Cancer statistics o Cancer prevention and early detection o Cancer disparities o Cancer survivorship o Cancer research.
NEW OPTIONS IN PROSTATE CANCER TREATMENT Presented by Triangle Urology Associates, P.A.
By Rachel, Xiao Xia, Helen. Introduction Definition Symptoms Causes Prevention Treatment Prognosis Statistics Conclusion.
Cancer Card Game Answers etc.
N212: Health Differences Across the Life Span 2
Colorectal Cancer Center Jena Introduction In Germany, there are currently approximately newly diagnosed patients with colorectal carcinoma.
HOW TO CONTROL CANCER Putting Science into Practice.
PRESENTING LUNG CANCER. Lung Cancer: Defined  Uncontrolled growth of malignant cells in one or both lungs and tracheo-bronchial tree  A result of repeated.
Resection For Lung Metastases M62 Coloproctology Course.
Surrogate End point for Prostate Cancer- Specific Mortality After RP or EBRT A D’Amico J Nat Ca Inst 95,
Retrospective Audit of Delayed Diagnosis of Hydronephrosis in Acute Kidney Injury John Dreisbach Radiology ST3 West of Scotland Deanery Acknowledgements:
Background  Reports of long-term survivors (≥5 years) of locally advanced esophageal cancer (LAEC) have focused mainly on HRQL or GI symptoms  Only.
Chemotherapy Audit  Audit of patients who died within three months of their last dose of chemotherapy at Airedale General Hospital  The records of 50.
The Colorectal Cancer Center Jena Gharbi A, Settmacher U. Department of General, Visceral and Vascular Surgery, Friedrich-Schiller-University Jena
Breast Cancer By: Christen Scott.
Regulating the Cell Cycle
Obstructive uropathies in children at UNTH Enugu
CANCER. Background Cells divide and multiply as the body needs them. Cells divide and multiply as the body needs them. When cells continue multiplying.
Breast Cancer in Ghana How are we going to ‘beat’ it? Prof J-N Clegg-Lamptey SAMF Launch.
Associated Web sites CustomizableMaps The Atlas On-Line.
Prostate Cancer: Treatment choices Prostate Cancer: Treatment choices Winston W Tan MD FACP Winston W Tan MD FACP Senior Consultant Senior Consultant Genitourinary.
Neuroendocrine Tumours
Oncology 11 Localised Prostate Cancer VIVA
FREEDOM FROM PROGRESSION FOR PATIENTS RECEIVING I 125 VERSUS Pd 103 FOR PROSTATE BRACHYTHERAPY Jane Cho, Carol Morgenstern, Barbara Napolitano, Lee Richstone,
Introduction to Radiation Therapy
Collaborative Study Proposal: Renal Cell Cancer in Lynch Syndrome.
Understanding Prostate Myths
Chapter 13: Reducing Your Risk of Cancer Cancer is a group of diseases characterized by uncontrolled, disorderly cell growth Cancer is the second-leading.
Consultant Obstetrician & Gynaecologist
The Cancer Registry of Norway Jan F Nygård Head of the IT-department.
Annals of Oncology 23: 298–304, 2012 종양혈액내과 R4 김태영 / prof. 김시영.
Supraclavicular metastasis from urothelial bladder carcinoma: A case report S. Farmahan, T. Mirza, P. Ameerally Oral Maxillofacial Department, Northampton.
Carcinoma of the prostate. INTRODUCTION Prostate cancer is the most common cancer diagnosed and is the second leading cause of cancer death in men in.
Prostate Cancer David Eedes 11 May Prostate Cancer Definition: Prostate cancer is a disease in which cells in the prostate gland become abnormal.
Completeness of linking identifiers Combining database structures South West Public Health Observatory Development of a urological cancer.
Presentation By: Jonathan, Marty and Kiran
CANCER.
UK Hospitalizations due to Stroke in Prostate Cancer Patients
Brain imaging prior to lung cancer resection
Multiple primary malignant tumors M P M T
Bronchial Carcinoma Part 2
1 Maidstone and Tunbridge Wells NHS Trust (Kent Oncology Centre)
Brain imaging prior to lung cancer resection
Treatment With Continuous, Hyperfractionated, Accelerated Radiotherapy (CHART) For Non-Small Cell Lung Cancer (NSCLC): The Weston Park Hospital Experience.
Cancer.
Fig. 1c: Cystoprostatectomy specimen
Unidade de Oncologia SPINAL CORD COMPRESSION ASSOCIATED TO METASTATIC PROSTATE CANCER Miguens, M. (1); Ferreira, F. (1); Malheiro, M. (1); Cardoso,
Maria Belgun, L.Dumitriu, A.Goldstein, Mariana Purice, F.Alexiu
أجهزة العلاج الإشعاعي Clinical Radiation Generator
The Nurse View: Best Practices in Advanced Non-Small Cell Lung Cancer
The BAHNO Head & Neck Cancer Surveillance Audit 2018
The BAHNO Head & Neck Cancer Surveillance Audit 2018
The STAR-TREC Trial SIV Presentation
Megan Eguchi, MPh Sana karam, md, phd
Clinical and Epidemiological Profile of children receiving
Three-year DFS rates of T x N subsets of the ACTS-CC trial and IDEA study.19 Annotation: definitions of DFS in ACTS-CC and IDEA were different. Three-year.
Presentation transcript:

Ademola Popoola,BUHARI TAJUDEEN,Fidelis Ushie,Hamid Olanipekun. Department of Surgery University of Ilorin Teaching Hospital,Ilorin. Multiple Primary Cancers -simultaneously occurring prostate cancer and other primary tumors: any link or coincidences?

Introduction  Prostate cancer is the most commonly diagnosed malignancy affecting men beyond middle age.  Is the most common non cutaneous malignancy in the Western world.  2 nd leading cause of cancer death in men.  It is a major public health burden in Sub Sahara Africa.  In practice, prostate cancer has been reported to occur simultaneously (synchronous) or successively (metachronous).

 Some multiple cancer syndromes have been well defined. These include Von Hippel Lindau Syndrome (cerebellar & retinal heamangioma, renal, pancreatic and spinal meningeal tumors). Introduction [Cont’d]

 To report Multiple Primary Cancers (MPC) involving Prostate cancer in our centre in the last two years.  To identify from the literature possible associations of simultaneously occurring cancers. Aim

 Retrospective analyses from our database of patients with MPC involving prostate cancer in the last two years.  Review of existing literature for possible association. Methodology

AgePSA/ GLEASON’S Score Duration Btw 1 sT & 2 ND Tumour Second Tumour TreatmentOutcome 75yrs121ng/ml 3+2 =5 SynchronousUrinary Bladder ChemotherapyDeath due to urosepsis (5months) 72yrs>50ng/ml 5+4 =9 Metachronous (2yrs) ColonLHRH, BTO, Permanent colostomy Died of complications of intestinal obstruction 84yrs116.7ng/ml 4+3=7 Metachronous (12months) ColonBTOStill being managed until strike 60yrs110ng/ml 3+2 =5 SynchronousRectumBTOImproved Parasthesia & urinary symptoms 72yrs45ng/ml 3+2=5 Metachronous (24months) ThyroidBTO, Chemotherapy, Thyroidectomy Death due to progression of Prostate cancer 70yrs60ng/ml 4+3=7 SynchronousliverSupportive careDeath due to hepatic failure Discussion

 Prostate cancer could occur with other primary tumours as synchronous or metachronous.  This has been adduced to increased life span and improved diagnostic tools.  There are existing literatures reporting prostate cancer occurring with all the other primary tumors in our series.  Lee et al; reported 4.03% finding of prostate cancer in radical cystoprostatectomy specimen (Asian J. Andrology, 2006). Discussion [Cont’d]

 The incidence of other primary tumours in the setting of primary liver cell carcinoma is relatively common with a strong clustering of genitourinary and gastro-intestinal malignancies.  Synchronous thyroid tumours have been reported following radiation for head and neck tumours. In our report, it was discovered after External beam radiation therapy to the pelvis.  Prostate cancer with Rectal cancer - Post Radiotherapy - Age Discussion [Cont’d]

 Prostate cancer with Colonic tumours - Genetics: (i) mutation of BRCA2 gene (ii) mutation of MMR gene (Lynch syndrome) Discussion [Cont’d]

 To make Diagnosis.  Diagnostic tools are limited: availability and affordability.  Between oncologic cure and preservation of functional anatomy/quality of life.  No established guideline.  Poor cancer registry.  Low rate of postmortem and radical procedures. Challenges

 MPC occurrence are probably more than the documented cases.  Detailed clinical evaluation is key.  There is need for more multidisciplinary approach to care.  There is also need for genetics study. Conclusion